Baxter Bros Inc’s Acceleron Pharma XLRN Stock Holding History

Baxter Bros Inc’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,550	Closed	-$267K	–	127
2021 Q3	$267K	Buy	+1,550	New	+$203K	0.04%	111
2021 Q2	–	Sell	-1,550	Closed	-$210K	–	124
2021 Q1	$210K	Buy	+1,550	New	+$200K	0.04%	120

Baxter Bros Inc's XLRN Position: Q4 2021 in Review

Baxter Bros Inc sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 1,550 shares — an estimated $267K sold.

Baxter Bros Inc first reported a position in XLRN in Q1 2021 and held it in 2 quarters. The position peaked at $267K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Baxter Bros Inc reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Baxter Bros Inc sold 1,550 Acceleron Pharma shares in Q4 2021, an estimated $267K.
Baxter Bros Inc first reported a position in Acceleron Pharma in Q1 2021 and held it in 2 quarters.
Baxter Bros Inc's Acceleron Pharma position peaked at $267K in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Baxter Bros Inc's 13F filing for Q4 2021, filed 14 Jan 2022.